Fred Poordad, M.D., of the UT Health Science Center San Antonio and Texas Liver Institute led the ALLY-1 trial. The overall cure rate for Hepatitis C patients with a liver transplant was 94 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback